Neurologic clinical trials - UCB CIDP01

Status:

Open (Study open and enrolling)

ClinicalTrials.gov:

NCT03052751

CONDITION(S): Chronic Inflammitory Demyelinating Polyneuropathy (CIDP) - TRIAL: UCB CIDP01 - A multicenter, randomized, subject-blind, investigator-blind, placebo-controlled, parallel group study evaluating the efficacy, safety, and tolerability of UCB7665 in subjects with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) phase 2A.

Trial Type

Interventional

Phase

Phase 2a

Condition

Chronic Inflammitory Demyelinating Polyneuropathy (CIDP)

Keywords

Chronic Inflammitory Demyelinating Polyneuropathy (CIDP) | UCB CIDP01